Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

C. Theodore, L. Geoffrois, J.B. Vermorken, F. Caponigro, W. Fiedler, P. Chollet, A. Ravaud, G.J. Peters, C. de Balincourt, D Lacombe, P Fumoleau

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1150-1157
JournalEuropean Journal of Cancer
Issue number8
Publication statusPublished - 2005

Cite this